Terminated PHASE4 INTERVENTIONAL 2-arm NCT02837783

A Study of the Effect of Linaclotide on Abdominal Girth in Participants With Irritable Bowel Syndrome With Constipation (IBS-C)

A Phase 4, Single-centre, Randomised, Double-blind, Placebo-controlled, Parallel-group, Fixed-dose Study of the Effect of Linaclotide on Abdominal Girth in Participants With Irritable Bowel Syndrome With Constipation

Sponsor: Ironwood Pharmaceuticals, Inc.

Conditions Irritable Bowel Syndrome Characterized by Constipation

Interventions Linaclotide Placebo

Updated 11 times since 2017 Last updated: Nov 1, 2021 Started: Dec 21, 2016 Primary completion: Oct 31, 2018 Completion: Oct 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Insufficient enrollment

Other terminated trials from Ironwood Pharmaceuticals, Inc.

More terminations from Ironwood Pharmaceuticals, Inc.

Listed as NCT02837783, this PHASE4 trial focuses on Irritable Bowel Syndrome Characterized by Constipation and remains terminated or withdrawn. Sponsored by Ironwood Pharmaceuticals, Inc., it has been updated 11 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2022 — Jul 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jan 2022 [monthly]

Terminated PHASE4
Feb 2020 — Jan 2021 [monthly]

Terminated PHASE4

Status: Completed → Terminated

▶ Show 6 earlier versions

Apr 2019 — Feb 2020 [monthly]

Completed PHASE4

Status: Recruiting → Completed
Jun 2018 — Apr 2019 [monthly]

Recruiting PHASE4
May 2018 — Jun 2018 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting
Feb 2018 — May 2018 [monthly]

Not Yet Recruiting PHASE4
Feb 2017 — Feb 2018 [monthly]

Not Yet Recruiting PHASE4
Jan 2017 — Feb 2017 [monthly]

Not Yet Recruiting PHASE4

First recorded

Dec 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ironwood Pharmaceuticals, Inc.
Manchester University NHS Foundation Trust

Data source: Ironwood Pharmaceuticals, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Wythenshawe, United Kingdom